"With significantly strengthened penalties, standardized reporting requirements and unprecedented enforcement commitments, the regulatory landscape has dramatically shifted," the AMA wrote. 

On a podcast with wellness guru Gary Brecka, HHS Secretary Robert F. Kennedy Jr. said major medical journals have succumbed to the corrupting influence of pharmaceutical companies, and he may ban scientists with the National Institutes of Health (NIH) from publishing in them.

The newly signed law, known as Act 264, bans pharmacy benefit managers from owning pharmacies in the state. It's scheduled to go into effect beginning in 2026.

The billionaire CEO of Tesla said his time serving in an official capacity in the Trump administration is at an end, though he will remain an advisor.

The analysis—required under an executive order from President Donald Trump—lists overmedicalization, excessive screen time, processed foods and environmental toxins as contributing factors for everything from cancer to ADHD.

A lack of Medicare reimbursement is just one issue. In a national survey, home healthcare agencies report dropping telemedicine offerings because elderly patients tend to prefer in-person care. 

The shift follows a paper published by the FDA in the New England Journal of Medicine last week, outlining a stricter framework for approving annual COVID-19 boosters and future vaccines.

A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions.